INOVIO Executives to Discuss DNA Medicines in Upcoming Fireside Chat

INOVIO Pharmaceuticals

PLYMOUTH MEETING, PAINOVIO (NASDAQ: INO) announced that President and CEO Dr. Jacqueline Shea and Chief Medical Officer Dr. Michael Sumner will participate in a virtual fireside chat. The event, hosted by Sudan Loganathan, Managing Director and equity research analyst at Stephens, Inc., will take place on Tuesday, June 11, 2024, at 11:00 am ET.

This fireside chat is exclusive to institutional clients of Stephens. Interested parties should contact their Stephens representatives for more information.

INOVIO, a biotechnology company, focuses on the development and commercialization of DNA medicines. These innovative treatments aim to combat HPV-related diseases, cancer, and infectious diseases. INOVIO’s technology enhances the design and delivery of DNA medicines, enabling the body to produce its own disease-fighting mechanisms.

The discussion will provide insights into INOVIO’s advancements and strategies in the biotechnology sector. Dr. Shea and Dr. Sumner are expected to shed light on the company’s ongoing projects and future plans, offering a rare glimpse into their cutting-edge work.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Boomi Unveils AI Agents: Revolutionizing Industrial Automation and Data Management